FIELD: medicine, cardiology. SUBSTANCE: method involves administration of aspirin in combination with quercitin. Method ensures to increase antianginal treatment effect, enhance antiaggregating action of therapy, decrease risk of thrombotic complications, shorten time of treatment by 2-3 times. Method can be used for prevention of disease progression at nitrate dose decrease. EFFECT: improved method of stenocardia treatment.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF NONSTABLE STENOCARDIA TREATMENT | 1992 |
|
RU2072842C1 |
| METHOD FOR ADJUSTING HEMORHEOLOGIC DISORDERS IN CARDIAC ISCHEMIA PATIENTS | 2004 |
|
RU2292861C2 |
| METHOD FOR TREATING THE CASES OF PROGRESSIVE ANGINA PECTORIS | 0 |
|
SU1747085A1 |
| METHOD FOR TREATMENT OF POSTINFARCTION STENOCARDIA | 1992 |
|
RU2062627C1 |
| METHOD FOR TREATING CARDIOVASCULAR DISEASE CASES | 2005 |
|
RU2286185C2 |
| METHOD FOR DETERMINING DEGREE OF SEVERITY OF STENOCARDIA IN PATIENTS SUFFERING FROM ISCHEMIA | 1991 |
|
RU2027999C1 |
| METHOD FOR EVALUATING THE DEGREE OF THERAPY AND DETERMINING THE INDICATIONS FOR ANTIOXIDANT THERAPY IN PATIENTS WITH ISCHEMIC CARDIAC DISEASE | 2001 |
|
RU2192643C1 |
| ANTIANGINAL AGENT | 2001 |
|
RU2200026C2 |
| ANTIANGINAL LIQUID AGENT FOR TRANSDERMAL USE | 1992 |
|
RU2064792C1 |
| METHOD OF TREATING ACUTE MYOCARDIAL INFARCTION | 1991 |
|
RU2027436C1 |
